Table 4. Multivariable analysis of selected demographic variables and ETS or DpR categorized by cutoff values.
Progression-free Survival | Overall Survival | ||||||
---|---|---|---|---|---|---|---|
Adjusted for Covariates | Adjusted for Covariates | ||||||
HR | 95% CI | P | HR | 95% CI | P | ||
Age | < 65 | Ref | Ref | ||||
≥ 65 | 0.816 | 0.433 to 1.540 | 0.531 | 0.945 | 0.441 to 2.026 | 0.885 | |
ECOG performance status | 0 | Ref | Ref | ||||
≥ 1 | 1.689 | 0.928 to 3.075 | 0.086 | 2.404 | 1.145 to 5.049 | 0.021 | |
HER2 overexpression by IHC | 2+ | Ref | Ref | ||||
3+ | 0.521 | 0.274 to 0.993 | 0.048 | 0.949 | 0.429 to 2.100 | 0.897 | |
ETS | < 30% | Ref | Ref | ||||
≥ 30% | 0.665 | 0.371 to 1.193 | 0.171 | 0.687 | 0.332 to 1.423 | 0.312 | |
Age | < 30% | Ref | Ref | ||||
≥ 65 | 0.896 | 0.488 to 1.626 | 0.720 | 1.025 | 0.488 to 2.147 | 0.950 | |
ECOG performance status | 0 | Ref | Ref | ||||
≥ 1 | 1.582 | 0.861 to 2.915 | 0.141 | 2.213 | 1.045 to 4.675 | 0.038 | |
HER2 overexpression by IHC | 2+ | Ref | Ref | ||||
3+ | 0.587 | 0.298 to 1.827 | 0.122 | 1.224 | 0.526 to 2.848 | 0.639 | |
DpR | < 45% | Ref | Ref | ||||
≥ 45% | 0.609 | 0.335 to 1.107 | 0.104 | 0.441 | 0.204 to 0.955 | 0.038 |
Abbreviations: HR, hazard ratio; CI, confidence interval; Ref, Reference; ECOG, Eastern Cooperative Oncology Group; HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry; ETS, early tumor shrinkage; DpR, depth of response